Wiebe Vanhove1, Kris Nys1, Ingrid Arijs1,2, Isabelle Cleynen3, Manuel Noben1,4, Sebastiaan De Schepper1, Gert Van Assche1,5, Marc Ferrante1,5, Séverine Vermeire1,5. 1. Translational Research in Gastrointestinal Disorders [TARGID], Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium. 2. Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium; Jessa Hospital, Hasselt, Belgium. 3. Laboratory for Complex Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium. 4. Department of Development and Regeneration, Stem Cell Institute Leuven, KU Leuven, Leuven, Belgium. 5. Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Abstract
BACKGROUND: Endoplasmic reticulum [ER] stress was shown to be pivotal in the pathogenesis of inflammatory bowel disease. Despite progress in inflammatory bowel disease [IBD] drug development, not more than one-third of patients achieve steroid-free remission and mucosal healing with current therapies. Furthermore, patient stratification tools for therapy selection are lacking. We aimed to identify and quantify epithelial ER stress in a patient-specific manner in an attempt towards personalised therapy. METHODS: A biopsy-derived intestinal epithelial cell culture system was developed and characterised. ER stress was induced by thapsigargin and quantified with a BiP enzyme-linked immunosorbent assay [ELISA] of cell lysates from 35 patients with known genotypes, who were grouped based on the number of IBD-associated ER stress and autophagy risk alleles. RESULTS: The epithelial character of the cells was confirmed by E-cadherin, ZO-1, and MUC2 staining and CK-18, CK-20, and LGR5 gene expression. Patients with three risk alleles had higher median epithelial BiP-induction [vs untreated] levels compared with patients with one or two risk alleles [p = 0.026 and 0.043, respectively]. When autophagy risk alleles were included and patients were stratified in genetic risk quartiles, patients in Q2, Q3, and Q4 had significantly higher ER stress [BiP] when compared with Q1 [p = 0.034, 0.040, and 0.034, respectively]. CONCLUSIONS: We developed and validated an ex vivo intestinal epithelial cell culture system and showed that patients with more ER stress and autophagy risk alleles have augmented epithelial ER stress responses. We thus presented a personalised approach whereby patient-specific defects can be identified, which in turn could help in selecting tailored therapies.
BACKGROUND: Endoplasmic reticulum [ER] stress was shown to be pivotal in the pathogenesis of inflammatory bowel disease. Despite progress in inflammatory bowel disease [IBD] drug development, not more than one-third of patients achieve steroid-free remission and mucosal healing with current therapies. Furthermore, patient stratification tools for therapy selection are lacking. We aimed to identify and quantify epithelial ER stress in a patient-specific manner in an attempt towards personalised therapy. METHODS: A biopsy-derived intestinal epithelial cell culture system was developed and characterised. ER stress was induced by thapsigargin and quantified with a BiP enzyme-linked immunosorbent assay [ELISA] of cell lysates from 35 patients with known genotypes, who were grouped based on the number of IBD-associated ER stress and autophagy risk alleles. RESULTS: The epithelial character of the cells was confirmed by E-cadherin, ZO-1, and MUC2 staining and CK-18, CK-20, and LGR5 gene expression. Patients with three risk alleles had higher median epithelial BiP-induction [vs untreated] levels compared with patients with one or two risk alleles [p = 0.026 and 0.043, respectively]. When autophagy risk alleles were included and patients were stratified in genetic risk quartiles, patients in Q2, Q3, and Q4 had significantly higher ER stress [BiP] when compared with Q1 [p = 0.034, 0.040, and 0.034, respectively]. CONCLUSIONS: We developed and validated an ex vivo intestinal epithelial cell culture system and showed that patients with more ER stress and autophagy risk alleles have augmented epithelial ER stress responses. We thus presented a personalised approach whereby patient-specific defects can be identified, which in turn could help in selecting tailored therapies.
Authors: M Angelico; G Tisone; L Baiocchi; G Palmieri; F Pisani; S Negrini; A Anselmo; G Vennarecci; C U Casciani Journal: Ital J Gastroenterol Hepatol Date: 1999 Aug-Sep
Authors: S Zeissig; N Bürgel; D Günzel; J Richter; J Mankertz; U Wahnschaffe; A J Kroesen; M Zeitz; M Fromm; J-D Schulzke Journal: Gut Date: 2006-07-05 Impact factor: 23.059
Authors: Walter Reinisch; Julian Panés; Marc Lémann; Stefan Schreiber; B Feagan; Steven Schmidt; Giacomo C Sturniolo; T Mikhailova; Olga Alexeeva; L Sanna; T Haas; S Korom; H Mayer Journal: Am J Gastroenterol Date: 2008-07-30 Impact factor: 10.864
Authors: Judith R Kelsen; Noor Dawany; Maire A Conrad; Tatiana A Karakasheva; Kelly Maurer; Jane M Wei; Selen Uman; Maiah H Dent; Rithika Behera; Laura M Bryant; Xianghui Ma; Leticia Moreira; Priya Chatterji; Rawan Shraim; Audrey Merz; Rei Mizuno; Lauren A Simon; Amanda B Muir; Claudio Giraudo; Edward M Behrens; Kelly A Whelan; Marcella Devoto; Pierre A Russo; Sarah F Andres; Kathleen E Sullivan; Kathryn E Hamilton Journal: Inflamm Bowel Dis Date: 2021-01-19 Impact factor: 5.325
Authors: Francisco Bravo; Jamie A Macpherson; Emma Slack; Nicolas Patuto; Julia Cahenzli; Kathy D McCoy; Andrew J Macpherson; Pascal Juillerat Journal: Clin Transl Gastroenterol Date: 2021-02-15 Impact factor: 4.488